Home / Compliance actions / 548342

FDA Warning Letter — Napa Valley Bioscience

Case 548342 — FEI 3014297051

The FDA took a Warning Letter action against Napa Valley Bioscience on May 18, 2018 (Santa Monica, CA). The action was issued by CFSAN and concerns food/cosmetics products.

Action Details

Facility
Napa Valley Bioscience
Date
May 18, 2018
Fiscal Year
2018
Product Type
Food/Cosmetics
Center
CFSAN
Location
Santa Monica, CA (United States)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.